Concepedia

David E. Kaelin

DE

16

Publications

721

Citations

15

H-Index

2000

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

The University of Texas at Austin

WuXi AppTec (China)

David E. Kaelin is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, drug discovery, and medicine.

Top concepts

PharmacologyMedicineDrug DiscoveryNatural SciencesAntimicrobial ResistanceMicrobiologyBiochemistryChemical BiologyMedicinal ChemistryDrug Resistance

Publications per year

2000–2016

16

Publications

16

Application of Ring-Closing Metathesis to the Formal Total Synthesis of (+)−FR900482

I.M. Fellows, David E. Kaelin, Stephen F. Martin · Journal of the American Chemical Society · 2000 · 104 citations

Medicinal Chemistry, Diversity Oriented Synthesis, Bioorganic Chemistry +13

General Strategies for the Synthesis of the Major Classes of <i>C</i>-Aryl Glycosides

David E. Kaelin, Omar D. Lopez, Stephen F. Martin · Journal of the American Chemical Society · 2001 · 86 citations

General Strategies, Molecular Sciences, Engineering +14

Oxabicyclooctane-Linked Novel Bacterial Topoisomerase Inhibitors as Broad Spectrum Antibacterial Agents

Sheo B. Singh, David E. Kaelin, Jin Wu et al. · ACS Medicinal Chemistry Letters · 2014 · 75 citations · Full text

Antimicrobial Chemotherapy, Drug Resistance, Am8191 Bound +16

Total Synthesis of (+)-Ambruticin S

Thomas A. Kirkland, John Colucci, Leo S. Geraci et al. · Journal of the American Chemical Society · 2001 · 73 citations

Diversity Oriented Synthesis, Bioorganic Chemistry, Biochemistry +9

Total Synthesis of Isokidamycin

B. Michael O’Keefe, Douglas M. Mans, David E. Kaelin et al. · Journal of the American Chemical Society · 2010 · 69 citations · Full text

Rows per page

1–5 of 16